Get the Daily Brief
Latest Biotech News
New AI-Driven Drug Discovery Platforms and Partnerships Advance Biopharma R&D
Biopharmaceutical innovation is accelerating as companies integrate AI and digital workflows to streamline compound design, synthesis, and testing. Ginkgo Bioworks, Inductive Bio, and Tangible...
Advancements in Brain Organoids Enabled by Graphene and Optical Stimulation
Researchers at the University of California San Diego’s Sanford Stem Cell Institute have pioneered Graphene-Mediated Optical Stimulation (GraMOS), a non-genetic, biocompatible method that uses...
Breakthroughs in Cancer Metabolism and Therapeutics Targeting Aggressive Tumors
Significant progress has been made in understanding and targeting aggressive cancers. UCSF researchers uncovered how triple-negative breast cancer (TNBC) cells directly interact with adipocytes,...
Regulatory and Financial Movements in Leading Biotechs Shape Industry Outlook
Sarepta Therapeutics announced a refinancing deal delaying approximately $700 million in convertible notes until 2030 to bolster its financial standing amid ongoing challenges, including setbacks...
AI and Machine Learning Transform Neurological Disease Diagnosis and Treatment
AI driven technologies are making substantial impacts in neurological disease management. Machine learning approaches have enabled models predicting kidney cancer treatment responses by...
Molecular and Genetic Insights Drive New Therapeutic Targets and Disease Understanding
Recent studies have unveiled key genetic and molecular mechanisms across a range of diseases. Whole exome sequencing linked FANCM mutations to estrogen receptor-negative breast cancer in...
Innovations in Biomedical Optics and Quantum Technologies Advance Research Frontiers
Researchers continue to make leaps in photonics and quantum science with potentially transformative impacts. A novel compact optical frequency comb device developed at MIT enhances chemical...
Gilead Buys Interius for Cell Therapy Push
Gilead Sciences has acquired Interius BioTherapeutics for $350 million, gaining exclusive rights to an innovative technology enabling genetic modification of immune cells inside the body. This...
AI and Automation Transform Biopharma R&D and Manufacturing
Leading biotech firms are integrating AI-driven workflows to accelerate drug discovery and bioprocessing. Ginkgo Bioworks, Inductive Bio, and Tangible Scientific announced a partnership to deliver...
Graphene-Based Stimulation Accelerates Brain Organoid Maturation
Researchers at UC San Diego have developed a novel graphene-mediated optical stimulation (GraMOS) technique to accelerate the maturation of human brain organoids. Utilizing graphene's unique...
Novel Tumor Suppressor Mechanism Identified in Blood Cancer
Scientists using genome-wide CRISPR screens have uncovered the GATOR1 complex as a critical tumor suppressor in Myc-driven lymphoma. This regulatory axis impedes cancer progression by modulating...
FDA Clears Ionis’ Drug for Hereditary Angioedema
The U.S. Food and Drug Administration approved Dawnzera, Ionis Pharmaceuticals' medication for hereditary angioedema, marking the third new drug approved this year for the rare genetic condition....
Superluminal and Eli Lilly Partner on Obesity Drugs with $1.3 Billion Pact
Superluminal Medicines, a Boston-based biotech specializing in AI-powered small molecule drug discovery, has entered a substantial collaboration with pharmaceutical giant Eli Lilly worth up to...
FDA Lifts Clinical Hold on Rocket Pharmaceuticals’ Gene Therapy Trial
Rocket Pharmaceuticals received FDA clearance to resume its Phase II gene therapy trial for Danon disease following a clinical hold prompted by a patient death. The trial will proceed at a lower...
Targeted mRNA-LNP Delivery Advances Therapeutics Beyond Vaccines
Monash University researchers have developed a targeted mRNA lipid nanoparticle (LNP) delivery system that improves cell specificity, overcoming a key limitation of conventional LNPs which lack...
Parkinson’s Therapy Improves with Neuromodulation and Wearable Monitoring
Innovative approaches in Parkinson’s disease management include the use of non-invasive neuromodulation devices and wearable technologies. Stimvia’s Uris device delivering transcutaneous...
Novel Antibiotic Structures Designed Using Generative AI Model
Researchers at the Massachusetts Institute of Technology developed a generative artificial intelligence model capable of designing novel antibiotic structures de novo and from chemical fragments....
Rocket Pharma Resumes Danon Gene Therapy Trial with FDA Approval
Rocket Pharmaceuticals has cleared a significant hurdle by obtaining FDA approval to resume its Phase 2 clinical trial of the RP-A501 gene therapy for Danon disease following a clinical hold...
Superluminal and Eli Lilly’s $1.3 Billion Collaboration Targets Cardiometabolic and Obesity Drugs
Superluminal Medicines announced a major partnership with Eli Lilly valued at up to $1.3 billion that will focus on discovering small molecule therapeutics against G protein-coupled receptors...
Graphene-Based Neuromodulation Accelerates Brain Organoid Development and Neuronal Function
Researchers at the University of California, San Diego, have developed Graphene-Mediated Optical Stimulation (GraMOS), a novel, non-genetic method utilizing graphene's optoelectronic properties to...